Financial Ratios Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Managed Healthcare

Market Closed - Nasdaq Other stock markets 02:30:00 15/01/2026 am IST			5-day change	1st Jan Change
21.74 ^USD	+3.94%		+3.89%	+10.10%

15/01	Alignment Healthcare Insider Sold Shares Worth $3,799,219, According to a Recent SEC Filing	MT
15/01	Alignment Healthcare, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 10:30 AM

d8b968377172.KzeZYSikH437CboVkwQODyvNb3iplfBncZtiYFpUWWI.Q1T4MG7AfN3LQ_5m0TRedU-DLByb37wgJPIKLCMZAFFjTfQVft1XzpplzQ

Published financial data: ALIGNMENT HEALTHCARE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Premiums and Annuity Revenues	96Cr	116.71Cr	143.16Cr	180.09Cr	267.19Cr
Other Revenues, Total	38.29L	7L	26.09L	2.27Cr	3.16Cr
Total Revenues	96Cr	116.78Cr	143.42Cr	182.36Cr	270.36Cr
Policy Benefits	79Cr	103.9Cr	124.99Cr	162.26Cr	240.69Cr
Depreciation & Amortization - (IS) - (Collected)	1.51Cr	1.58Cr	1.73Cr	2.14Cr	2.63Cr
Selling General & Admin Expenses, Total	16Cr	29Cr	30Cr	31Cr	37Cr
Total Operating Expenses	96Cr	134.58Cr	156.28Cr	194.95Cr	280.2Cr
Operating Income	-52.63L	-18Cr	-13Cr	-13Cr	-9.85Cr
Interest Expense, Total	-1.69Cr	-1.74Cr	-1.83Cr	-2.12Cr	-2.35Cr
Other Non Operating Income (Expenses)	3L	2L	-75T	6L	2L
EBT, Excl. Unusual Items	-2.19Cr	-20Cr	-15Cr	-15Cr	-12Cr
Restructuring Charges	-	-	-	-	-15.67L
Gain (Loss) on Sale of Assets	-10.06L	-	-1L	3L	9T
Asset Writedown	-	-	-	-	-7L
Legal Settlements	-	-	-	-19L	-9L
Other Unusual Items	-	-	-21.96L	-	-30.2L
EBT, Incl. Unusual Items	-2.29Cr	-20Cr	-15Cr	-15Cr	-13Cr
Income Tax Expense	-	-	3L	-22T	21T
Earnings From Continuing Operations	-2.29Cr	-20Cr	-15Cr	-15Cr	-13Cr
Net Income to Company	-2.29Cr	-20Cr	-15Cr	-15Cr	-13Cr
Minority Interest	-	-	92T	2L	36T
Net Income - (IS)	-2.29Cr	-20Cr	-15Cr	-15Cr	-13Cr
Net Income to Common Incl Extra Items	-2.29Cr	-20Cr	-15Cr	-15Cr	-13Cr
Net Income to Common Excl. Extra Items	-2.29Cr	-20Cr	-15Cr	-15Cr	-13Cr
Per Share Items
Net EPS - Basic	-36.92	-1.14	-0.83	-0.79	-0.67
Basic EPS - Continuing Operations	-36.92	-1.14	-0.83	-0.79	-0.67
Basic Weighted Average Shares Outstanding	6L	17Cr	18Cr	19Cr	19Cr
Net EPS - Diluted	-36.92	-1.14	-0.83	-0.79	-0.67
Diluted EPS - Continuing Operations	-36.92	-1.14	-0.83	-0.79	-0.67
Diluted Weighted Average Shares Outstanding	6L	17Cr	18Cr	19Cr	19Cr
Normalized Basic EPS	-22.06	-0.71	-0.51	-0.49	-0.4
Normalized Diluted EPS	-22.06	-0.71	-0.51	-0.49	-0.4
Supplemental Items
EBITDA	1.02Cr	-16Cr	-11Cr	-10Cr	-7.14Cr
EBITA	-49.36L	-18Cr	-13Cr	-13Cr	-9.78Cr
EBIT	-52.63L	-18Cr	-13Cr	-13Cr	-9.85Cr
EBITDAR	1.39Cr	-16Cr	-11Cr	-10Cr	-6.86Cr
Total Revenues (As Reported)	96Cr	116.78Cr	143.42Cr	182.36Cr	270.36Cr
Effective Tax Rate - (Ratio)	-	-	-0.23	0.01	-0.02
Normalized Net Income	-1.37Cr	-12Cr	-9.18Cr	-9.15Cr	-7.61Cr
Interest on Long-Term Debt	1.69Cr	1.74Cr	1.83Cr	2.12Cr	2.35Cr
Supplemental Operating Expense Items
Advertising Expense	-	35.81L	79.58L	69.56L	57.56L
Selling and Marketing Expenses	-	35.81L	79.58L	69.56L	57.56L
Net Rental Expense, Total	36.7L	36.02L	33.74L	26.83L	27.9L
Imputed Operating Lease Interest Expense	33.62L	31.5L	29.91L	26.7L	20.9L
Imputed Operating Lease Depreciation	3L	5L	4L	12.66T	7L
Stock-Based Comp., SG&A Exp. (Total)	21.24L	11Cr	7.26Cr	5.93Cr	6.62Cr
Stock-Based Comp., Other (Total)	-	1.54Cr	91.28L	75.41L	49.3L
Total Stock-Based Compensation	21.24L	12Cr	8.17Cr	6.68Cr	7.11Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Total Other Investments	-	-	-	12Cr	3.78Cr
Total investments	-	-	-	12Cr	3.78Cr
Cash And Equivalents	21Cr	47Cr	41Cr	20Cr	43Cr
Other Receivables - (Insurance Template)	4.01Cr	5.85Cr	9.29Cr	12Cr	15Cr
Gross Property Plant And Equipment	11Cr	13Cr	15Cr	19Cr	22Cr
Accumulated Depreciation	-7.27Cr	-8.82Cr	-11Cr	-12Cr	-15Cr
Net Property Plant And Equipment	3.7Cr	3.82Cr	4.3Cr	6.19Cr	7.5Cr
Goodwill	2.93Cr	2.93Cr	3.48Cr	3.48Cr	3.48Cr
Other Intangibles, Total	53.42L	58.13L	54.78L	52.52L	45.5L
Other Current Assets, Total	1.72Cr	2.77Cr	4.21Cr	4.5Cr	3.71Cr
Other Long-Term Assets, Total	21.48L	47.09L	60.35L	64.05L	60.92L
Total Assets	34Cr	63Cr	63Cr	59Cr	78Cr
Liabilities
Accounts Payable, Total	1.23Cr	1.37Cr	2.81Cr	2.09Cr	2Cr
Accrued Expenses, Total	14Cr	15Cr	20Cr	24Cr	33Cr
Current Portion of Leases	33.51L	37.06L	42.02L	17.17L	12.12L
Long-Term Debt	14Cr	15Cr	16Cr	16Cr	32Cr
Long-Term Leases	1.03Cr	69.75L	36.98L	89.74L	78.35L
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	-	-	-	9L	9L
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	31Cr	32Cr	39Cr	43Cr	68Cr
Common Stock, Total	-	2L	2L	2L	2L
Additional Paid In Capital	-	88Cr	97Cr	103.7Cr	110.8Cr
Retained Earnings	3.06Cr	-57Cr	-73Cr	-88Cr	-100.83Cr
Total Common Equity	3.06Cr	31Cr	24Cr	16Cr	9.99Cr
Minority Interest	-	15T	11.76L	11.25L	11.04L
Total Equity	3.06Cr	31Cr	24Cr	16Cr	10Cr
Total Liabilities And Equity	34Cr	63Cr	63Cr	59Cr	78Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	6L	19Cr	19Cr	19Cr	19Cr
ECS Total Common Shares Outstanding	6L	19Cr	19Cr	19Cr	19Cr
Book Value / Share	49.3	1.63	1.27	0.83	0.52
Tangible Book Value	-40.34L	27Cr	20Cr	12Cr	6.05Cr
Tangible Book Value Per Share	-6.5	1.45	1.06	0.62	0.32
Total Debt	16Cr	16Cr	17Cr	17Cr	33Cr
Net Debt	-4.95Cr	-31Cr	-24Cr	-3.04Cr	-10Cr
Debt Equivalent Oper. Leases	2.94Cr	2.88Cr	2.7Cr	2.15Cr	2.23Cr
Minority Interest, Total (Incl. Fin. Div)	-	15T	11.76L	11.25L	11.04L
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	1.27Cr	1.36Cr	1.54Cr	1.58Cr	1.69Cr
Full Time Employees	775	847	1.04T	1.54T	1.68T

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-2.29Cr	-20Cr	-15Cr	-15Cr	-13Cr
Depreciation, Depletion & Amortization	1.51Cr	1.57Cr	1.71Cr	2.14Cr	2.64Cr
Amortization of Goodwill and Intangible Assets - (CF)	3L	4L	4L	2L	7L
Total Depreciation, Depletion & Amortization	1.55Cr	1.6Cr	1.75Cr	2.17Cr	2.71Cr
Amortization of Deferred Charges, Total	21.92L	22.54L	18.5L	-	12.93L
(Gain) Loss On Sale of Asset - (CF)	10.06L	-	6L	-	-9T
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-25.79L
Total Asset Writedown	-	-	-	-3L	1L
Stock-Based Compensation (CF)	21.24L	11Cr	8.17Cr	6.68Cr	7.11Cr
Provision and Write-off of Bad Debts	1L	1L	2L	91T	1L
Change in Accounts Receivable	-46.27L	-1.76Cr	-3.44Cr	-2.7Cr	-3.43Cr
Change in Accounts Payable	6L	4L	1.37Cr	-63.47L	-14.6L
Change in Other Net Operating Assets (Collected)	72.36L	-22.45L	1.51Cr	3.53Cr	9.66Cr
Other Operating Activities	63.32L	69.28L	78.58L	-15.01L	47.48L
Cash from Operations	75.61L	-7.88Cr	-4.54Cr	-5.92Cr	3.48Cr
Capital Expenditure	-1.57Cr	-1.98Cr	-2.38Cr	-3.6Cr	-4.14Cr
Sale of Property, Plant, and Equipment	1L	-	-	-	14T
Cash Acquisitions	-	-	-40.43L	-	-
Investment in Marketable and Equity Securities, Total	-8L	-10.5L	-4L	-11Cr	8.06Cr
Cash from Investing	-1.64Cr	-2.08Cr	-2.82Cr	-15Cr	3.92Cr
Long-Term Debt Issued, Total	-	-	16Cr	-	38Cr
Total Debt Issued	-	-	16Cr	-	38Cr
Long-Term Debt Repaid, Total	-	-	-14Cr	-	-22Cr
Total Debt Repaid	-	-	-14Cr	-	-22Cr
Issuance of Common Stock	14Cr	39Cr	-	-	2L
Repurchase of Common Stock	-15.05L	-14.74L	-	-	-4L
Other Financing Activities, Total	-33.71L	-2.9Cr	-52.28L	1L	-87.77L
Cash from Financing	13Cr	36Cr	1.66Cr	1L	16Cr
Net Change in Cash	12Cr	26Cr	-5.71Cr	-21Cr	23Cr
Supplemental Items
Cash Interest Paid	1.07Cr	1.1Cr	2.24Cr	1.92Cr	2.22Cr
Net Debt Issued / Repaid	-	-	2.18Cr	-	16Cr
Levered Free Cash Flow	-64.54L	-1.71Cr	-10.68L	-15Cr	12Cr
Unlevered Free Cash Flow	19.36L	-84.84L	85.13L	-14Cr	14Cr
Change In Net Working Capital	-33.48L	1.55Cr	-1.35Cr	11Cr	-14Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-1.24	-22.96	-12.71	-12.84	-8.96
Return on Total Capital	-2.66	-33.94	-18.37	-21.31	-16.15
Return On Equity %	95.33	-116.01	-54.88	-74.58	-98.89
Return on Common Equity	95.33	-116.02	-54.96	-74.93	-99.72
Margin Analysis
Gross Profit Margin %	17.33	11.02	12.85	11.02	10.97
SG&A Margin	16.3	24.92	20.61	16.75	13.64
EBITDA Margin %	1.06	-13.88	-7.75	-5.72	-2.64
EBITA Margin %	-0.51	-15.22	-8.94	-6.89	-3.62
EBIT Margin %	-0.55	-15.25	-8.97	-6.9	-3.64
Income From Continuing Operations Margin %	-2.39	-16.72	-10.43	-8.13	-4.74
Net Income Margin %	-2.39	-16.72	-10.43	-8.12	-4.74
Net Avail. For Common Margin %	-2.39	-16.72	-10.43	-8.12	-4.74
Normalized Net Income Margin	-1.43	-10.45	-6.4	-5.02	-2.81
Levered Free Cash Flow Margin	-0.67	-1.47	-0.07	-8.2	4.55
Unlevered Free Cash Flow Margin	0.2	-0.73	0.59	-7.47	5.05
Asset Turnover
Asset Turnover	3.61	2.41	2.27	2.98	3.94
Fixed Assets Turnover	29.75	31.04	35.32	34.78	39.52
Short Term Liquidity
Current Ratio	1.72	3.31	2.37	1.84	1.88
Quick Ratio	1.61	3.14	2.18	1.67	1.78
Operating Cash Flow to Current Liabilities	0.05	-0.47	-0.2	-0.23	0.1
Average Days Payable Outstanding	6.39	4.58	6.1	5.51	3.18
Long Term Solvency
Total Debt/Equity	515.47	52.7	70.54	109.13	327.35
Total Debt / Total Capital	83.75	34.51	41.36	52.18	76.6
LT Debt/Equity	504.52	51.49	68.78	108.04	326.15
Long-Term Debt / Total Capital	81.97	33.72	40.33	51.66	76.32
Total Liabilities / Total Assets	90.96	51.49	62.25	73.29	87.09
EBIT / Interest Expense	-0.31	-10.21	-7.03	-5.93	-4.18
EBITDA / Interest Expense	0.82	-9.08	-5.89	-4.78	-2.91
(EBITDA - Capex) / Interest Expense	-0.11	-10.22	-7.19	-6.48	-4.67
Total Debt / EBITDA	11.38	-1.02	-1.57	-1.7	-4.82
Net Debt / EBITDA	-3.57	1.93	2.23	0.3	1.49
Total Debt / (EBITDA - Capex)	-85.76	-0.91	-1.28	-1.25	-3
Net Debt / (EBITDA - Capex)	26.91	1.71	1.83	0.22	0.93
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	26.72	21.74	22.81	27.16	48.25
Gross Profit, 1 Yr. Growth %	73.93	-22.56	43.15	9.09	47.59
EBITDA, 1 Yr. Growth %	-179.05	-1.69T	-31.4	-6.21	-32.72
EBITA, 1 Yr. Growth %	-83.07	3.5T	-27.83	-2	-23.37
EBIT, 1 Yr. Growth %	-82.15	3.28T	-27.76	-2.12	-22.96
Earnings From Cont. Operations, 1 Yr. Growth %	-48.75	751.81	-23.37	-0.98	-13.57
Net Income, 1 Yr. Growth %	-48.75	751.81	-23.42	-1.02	-13.5
Normalized Net Income, 1 Yr. Growth %	-50.53	790.9	-24.8	-0.01	-17.86
Diluted EPS Before Extra, 1 Yr. Growth %	-53.27	653.61	-27.33	-3.68	-15.58
Net Property, Plant and Equip., 1 Yr. Growth %	34.95	3.18	12.52	43.88	21.17
Total Assets, 1 Yr. Growth %	74.99	86.38	0.47	-6.62	32.13
Common Equity, 1 Yr. Growth %	-138.89	899.77	-22.19	-34.09	-36.38
Tangible Book Value, 1 Yr. Growth %	-96.45	-6.82T	-26.98	-40.93	-48.25
Cash From Operations, 1 Yr. Growth %	-17.89	-1.14T	-42.33	30.29	-158.75
Capital Expenditures, 1 Yr. Growth %	53.32	25.83	20.28	51.4	15.07
Levered Free Cash Flow, 1 Yr. Growth %	-	165.44	-93.77	5.03T	-182.28
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-538.31	-200.34	-1.7T	-199.23
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	24.21	22.28	24.97	37.3
Gross Profit, 2 Yr. CAGR %	-	16.06	5.29	24.96	26.89
EBITDA, 2 Yr. CAGR %	-	254.4	230.14	-19.79	-19.85
EBITA, 2 Yr. CAGR %	-	146.88	409.74	-15.9	-12.69
EBIT, 2 Yr. CAGR %	-	145.76	394.39	-15.91	-12.51
Earnings From Cont. Operations, 2 Yr. CAGR %	-	108.94	155.48	-12.89	-7.49
Net Income, 2 Yr. CAGR %	-	108.94	155.4	-12.94	-7.47
Normalized Net Income, 2 Yr. CAGR %	-	109.93	158.84	-13.44	-8.79
Diluted EPS Before Extra, 2 Yr. CAGR %	-	85.72	134.01	-16.34	-9.82
Net Property, Plant and Equip., 2 Yr. CAGR %	-	18	7.75	27.24	32.04
Total Assets, 2 Yr. CAGR %	-	80.59	36.84	-3.14	11.08
Common Equity, 2 Yr. CAGR %	-	97.18	178.91	-28.39	-35.25
Tangible Book Value, 2 Yr. CAGR %	-	54.38	600.3	-34.32	-44.71
Cash From Operations, 2 Yr. CAGR %	-	192.49	145.11	-13.32	-12.51
Capital Expenditures, 2 Yr. CAGR %	-	38.9	23.02	34.95	31.99
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-59.32	177.75	973.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	109.71	300.79	300.31
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	23.74	23.88	32.29
Gross Profit, 3 Yr. CAGR %	-	-	24.47	6.54	32.09
EBITDA, 3 Yr. CAGR %	-	-	105.01	117.03	-23.9
EBITA, 3 Yr. CAGR %	-	-	63.85	194.2	-18.06
EBIT, 3 Yr. CAGR %	-	-	63.4	188.15	-17.92
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	49.56	86.27	-13.12
Net Income, 3 Yr. CAGR %	-	-	49.53	86.21	-13.13
Normalized Net Income, 3 Yr. CAGR %	-	-	49.09	88.29	-14.57
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	35.84	74.07	-16.09
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	16.14	18.65	25.18
Total Assets, 3 Yr. CAGR %	-	-	48.53	20.47	7.42
Common Equity, 3 Yr. CAGR %	-	-	44.63	72.43	-31.16
Tangible Book Value, 3 Yr. CAGR %	-	-	20.28	207.13	-39.34
Cash From Operations, 3 Yr. CAGR %	-	-	70.24	98.56	-23.86
Capital Expenditures, 3 Yr. CAGR %	-	-	32.39	31.84	27.97
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	185.09	85.12
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	312.92	152.4
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	28.99
Gross Profit, 5 Yr. CAGR %	-	-	-	-	25.43
EBITDA, 5 Yr. CAGR %	-	-	-	-	40.81
EBITA, 5 Yr. CAGR %	-	-	-	-	27.38
EBIT, 5 Yr. CAGR %	-	-	-	-	27.28
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	23.41
Net Income, 5 Yr. CAGR %	-	-	-	-	23.41
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	22.4
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	15.31
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	22.26
Total Assets, 5 Yr. CAGR %	-	-	-	-	32.23
Common Equity, 5 Yr. CAGR %	-	-	-	-	4.87
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	-11.86
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	30.44
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	32.23